Literature DB >> 10783011

Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia.

H Murakami1, N Tamasawa, J Matsui, M Yasujima, T Suda.   

Abstract

The plasma levels of free oxysterols (7-ketocholesterol; 7alpha-hydroxy-, 7beta-hydroxy-, 25-hydroxy-, and 27-hydroxycholesterol; and 5alpha,6alpha-epoxycholestanol) in patients with diabetes mellitus and hypercholesterolemia were determined using gas chromatography-mass spectrometry with selective ion monitoring. We studied 39 patients with diabetes mellitus, 20 nondiabetic patients with hypercholesterolemia, and 37 normal controls. Plasma cholesterol levels in diabetic and hypercholesterolemic patients showed no statistical difference. Plasma 7-ketocholesterol was significantly higher in patients with diabetes (31.6+/-2.8 ng/mL) or hypercholesterolemia (52.3+/-5.9) than in the control group (22.4+/-1.2). The increased plasma cholesterol can be regarded as an oxidation substrate for the oxidant stress and the higher absolute levels of oxysterols in hypercholesterolemic plasma compared with the control plasma. This difference disappeared when 7-ketocholesterol was expressed in proportion to total cholesterol. The oxidizability of plasma cholesterol was evaluated by comparing the increased ratio of 7-ketocholesterol after CuSO4 oxidation to the ratio before. We demonstrated that the patients with diabetes showed increased oxidizability (77.5%) compared with the control (36.6%) or hyperlipemic group (45.3%), which is likely due to the lower amounts of alpha-tocopherol in the diabetics. Measurement of oxysterols may serve as a marker for in vivo oxidized lipoproteins in diabetes and hyperlipemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783011     DOI: 10.1007/s11745-000-0530-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  27 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  LDL- is a lipid hydroperoxide-enriched circulating lipoprotein.

Authors:  A Sevanian; G Bittolo-Bon; G Cazzolato; H Hodis; J Hwang; A Zamburlini; M Maiorino; F Ursini
Journal:  J Lipid Res       Date:  1997-03       Impact factor: 5.922

Review 3.  Biological activities of oxysterols.

Authors:  L L Smith; B H Johnson
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

4.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  Lipoprotein oxidation and lipoprotein-induced cytotoxicity.

Authors:  J R Hessler; D W Morel; L J Lewis; G M Chisolm
Journal:  Arteriosclerosis       Date:  1983 May-Jun

6.  The effect of diabetes on the activities of the peroxide metabolism enzymes.

Authors:  B Matkovics; S I Varga; L Szabó; H Witas
Journal:  Horm Metab Res       Date:  1982-02       Impact factor: 2.936

7.  Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper.

Authors:  K L Carpenter; G M Wilkins; B Fussell; J A Ballantine; S E Taylor; M J Mitchinson; D S Leake
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

8.  Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations.

Authors:  M S Jacobson
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

9.  Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages.

Authors:  I Björkhem; O Andersson; U Diczfalusy; B Sevastik; R J Xiu; C Duan; E Lund
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

10.  Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-).

Authors:  H N Hodis; D M Kramsch; P Avogaro; G Bittolo-Bon; G Cazzolato; J Hwang; H Peterson; A Sevanian
Journal:  J Lipid Res       Date:  1994-04       Impact factor: 5.922

View more
  12 in total

1.  Srebp-controlled glucose metabolism is essential for NK cell functional responses.

Authors:  Nadine Assmann; Katie L O'Brien; Raymond P Donnelly; Lydia Dyck; Vanessa Zaiatz-Bittencourt; Róisín M Loftus; Paul Heinrich; Peter J Oefner; Lydia Lynch; Clair M Gardiner; Katja Dettmer; David K Finlay
Journal:  Nat Immunol       Date:  2017-09-18       Impact factor: 25.606

2.  Anti-inflammatory and Cytoprotective Effect of Clinacanthus nutans Leaf But Not Stem Extracts on 7-Ketocholesterol Induced Brain Endothelial Cell Injury.

Authors:  Xuan Kuo; Deron R Herr; Wei-Yi Ong
Journal:  Neuromolecular Med       Date:  2020-10-21       Impact factor: 3.843

3.  Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest.

Authors:  Z X Meng; J Nie; J J Ling; J X Sun; Y X Zhu; L Gao; J H Lv; D Y Zhu; Y J Sun; X Han
Journal:  Diabetologia       Date:  2008-10-24       Impact factor: 10.122

4.  Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.

Authors:  Z X Meng; Y Yin; J H Lv; M Sha; Y Lin; L Gao; Y X Zhu; Y J Sun; X Han
Journal:  Diabetologia       Date:  2012-03-14       Impact factor: 10.122

5.  The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain.

Authors:  Catrina Sims-Robinson; Anna Bakeman; Andrew Rosko; Rebecca Glasser; Eva L Feldman
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

6.  Oncogenic roles of the cholesterol metabolite 25-hydroxycholesterol in bladder cancer.

Authors:  Chen Wang; Haowei He; Wennian Fang
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

7.  Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage.

Authors:  Antje Diestel; Orhan Aktas; Dagmar Hackel; Ines Hake; Susanne Meier; Cedric S Raine; Robert Nitsch; Frauke Zipp; Oliver Ullrich
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

Review 8.  Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes.

Authors:  Lin Ding; Shuguang Pang; Yongmei Sun; Yuling Tian; Li Yu; Ningning Dang
Journal:  Int J Endocrinol       Date:  2014-04-28       Impact factor: 3.257

Review 9.  Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.

Authors:  Wei-Yi Ong; Mei-Lin Go; De-Yun Wang; Irwin Kee-Mun Cheah; Barry Halliwell
Journal:  Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.590

Review 10.  Oxidized cholesterol species as signaling molecules in the brain: diabetes and Alzheimer's disease.

Authors:  Thaddeus K Weigel; Joshua A Kulas; Heather A Ferris
Journal:  Health Psychol Behav Med       Date:  2019-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.